Evolve
Research payments
$3,345,501
Through program year 2025, $3,345,501 in research payments was reported against Evolve, across 487 payments.
- Paid by (largest first)
- Stryker Corporation; Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $517,782 | 95 |
| 2024 | Research | $990,911 | 131 |
| 2023 | Research | $556,121 | 68 |
| 2022 | Research | $580,168 | 67 |
| 2021 | Research | $381,640 | 85 |
| 2020 | Research | $118,814 | 38 |
| 2019 | Research | $200,065 | 3 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Alexander Coon Baltimore, MD Named on 37 payments
- Emanuele Orru' Burlington, MA Named on 21 payments
- Koji Ebersole Kansas City, KS Named on 14 payments
- Gaurav Gupta New Brunswick, NJ Named on 14 payments
- David Fiorella Stony Brook, NY Named on 13 payments
- Justin Singer Grand Rapids, MI Named on 13 payments
- Demetrius Lopes Park Ridge, IL Named on 13 payments
- Santiago Ortega Gutierrez Iowa City, IA Named on 12 payments
- Ryan Priest Portland, OR Named on 11 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.